Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T17:18:11.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with an access-restriction notice and standard site chrome.
    Difference
    0.5%
    Check dated 2026-09-28T19:18:35.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page with basic navigation, indicating access is blocked. The previously visible study content and related sections such as CSR Synopsis, AstraZeneca details, and IPD sharing information were removed.
    Difference
    15%
    Check dated 2026-09-21T22:43:55.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the page.
    Difference
    0.1%
    Check dated 2026-08-31T16:19:53.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Footer version updated from v3.6.4 to v3.6.5, indicating a minor platform update with no changes to study information.
    Difference
    0.1%
    Check dated 2026-08-10T11:38:45.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a site-wide software update. This appears to be a backend release that does not modify the study details or displayed content.
    Difference
    0.1%
    Check dated 2026-07-27T05:55:15.000Z thumbnail image

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.